[1]
2024. Semaglutide, Tirzepatide and the Cardiologist: Weight-Directed Therapy as Cardiovascular Therapy. Journal of Heart and Cardiovascular Science. 5, 1 (Sep. 2024), 1–3. DOI:https://doi.org/10.5281/zenodo.22365904.